Our results demonstrated that the percentage of peripheral Th22 subset (defined as CD4+IL-22+IL-17−IFNγ−) was markedly elevated in MDS patients compared with healthy donors, and notably higher in L-MDS than in E-MDS. The gene discussed is IL22; the disease is myelodysplastic syndrome.